Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
33.95
+0.88 (2.66%)
At close: Sep 21, 2026, 4:00 PM EDT
33.79
-0.16 (-0.47%)
After-hours: Sep 21, 2026, 7:30 PM EDT
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $2.03 billion as of September 21, 2026. Its market cap has decreased by -7.47% in one year.
Market Cap
2.03B
Enterprise Value
1.09B
1-Year Change
-7.47%
Ranking
Category
Stock Price
$33.95
ChartMarket Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $2.03B, an increase of 120.55%. That is a compound annual growth rate of 6.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 2.03B | 27.69% |
| Dec 31, 2025 | 1.59B | -15.30% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
| Jul 24, 2013 | 919.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 2.05B |
| Recursion Pharmaceuticals | 2.05B |
| Zenas BioPharma | 2.05B |
| Kodiak Sciences | 2.05B |
| Vericel | 2.05B |
| ADMA Biologics | 2.04B |
| Mesoblast | 1.95B |
| Rapport Therapeutics | 1.94B |